Nucor Analysts Raise Targets Before Monday's Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

NUE reports Q3 results on Monday, October 26, with the most notable pre-earnings signal coming not from shorts but from the analyst community, where Barclays lifted its target to $306 four days ago, the highest on record among recent changes, while the Street's mean sits at $285 against a current price of $258.06.
Options positioning tells a different story from the analyst optimism. Call-side activity has been gaining ground relative to puts, with the put/call ratio dropping to 0.75, well below its 20-day average of 0.81 and the furthest from defensive positioning it has been in the past year. That marks a reversal from mid-September, when the ratio was running near its 52-week high of 0.87. The shift points to growing call-side interest ahead of Monday's release, even after NUE fell 2.4% on Thursday to close at $258.06.
Analyst moves in recent weeks have cut in two directions. Barclays raised its target to $306 just this past Monday, maintaining an Overweight rating, while JPMorgan trimmed to $296 from $308 on October 9, also keeping Overweight. Earlier in October, Keybanc nudged its target down to $286. The net picture is a Wall Street consensus that remains constructively positioned, with the mean target implying about 10% upside to current levels, but one where individual firms are pulling back their numbers as the steel pricing environment stays uncertain. Freedom Broker was the only firm to actually cut its rating, moving to Hold in mid-September.
The lending market adds no drama. Short interest is minimal at 1.9% of the free float, down slightly over the past week, and share availability is effectively unconstrained. Borrowing costs, at 0.37%, have ticked up about 18% in the past week but remain negligible in absolute terms. There is no meaningful short-side pressure heading into the release.
One detail worth noting in the ownership picture: Berkshire Hathaway trimmed its stake by just over 2 million shares in the most recent reporting period, cutting its holding to below 0.9% of shares. The index-fund anchors, BlackRock, Vanguard Capital Management and State Street, all added modestly in the most recently reported quarters. Insider activity from the summer skews negative on a net basis: CEO Leon Topalian sold roughly $7 million of stock on August 14, with the COO and an Executive Vice President also selling in the same period. None of the sales were disclosed as part of a 10b5-1 plan, though all trades are now roughly ten weeks in the past.
Peer moves on Thursday give some context for the sector mood. STLD dropped 3.3% on the day, CLF fell nearly 7%, and CMC slid 0.7%. NUE's own 2.4% decline was broadly in line with the sector, and the stock is up 1.3% over the past week, roughly matching the peer median. The Monday print will test whether NUE's premium valuation relative to trough steel earnings, currently trading at a PE near 12.5 and EV/EBITDA of about 8, holds up once the company's own volume and pricing data is on the table.
Against its peers
Shares moved +1.3% over the past week against a median of +1.2% for its closest peers.
Stocks in this article
See the live data behind this article on ORTEX.
Open NUE on ORTEX →How this article was generated
- Generated
- 23 Oct 2026, 04:07
- Data as of
- 23 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.